Persistent and anatomically selective reduction in prefrontal cortical dopamine
metabolism after repeated, intermittent cannabinoid administration to rats
Verrico CD, Jentsch JD, Roth RH.
Department of Pharmacology,
Yale University School of Medicine,
New Haven, Connecticut 06510.
Synapse 2003 Jul;49(1):61-6
ABSTRACTLong-term abuse of delta-9-tetrahydrocannabinol (THC), the major psychoactive constituent of marijuana, produces behavioral and metabolic signs of frontal cortical dysfunction in humans; these effects persist even after short-term abstinence. Based on a preliminary finding that repeated administration of THC to rats reduces basal frontal cortical dopamine turnover (Jentsch et al.  Neurosci Lett 246:169-172), we further investigated the effects of repeated administrations of THC or WIN 55,212-2 (WIN), a synthetic cannabinoid receptor agonist, on dopamine turnover in the prefrontal cortex, striatum, and nucleus accumbens. THC or WIN (twice daily for 7 or 14 days) caused a persistent and selective reduction in medial prefrontal cortical dopamine turnover; no significant alterations of dopamine metabolism were observed in the nucleus accumbens or striatum. Importantly, these dopaminergic deficits in the prefrontal cortex were observed after a drug-free period of up to 14 days. Thus, the cognitive dysfunction produced by heavy, long-term cannabis use may be subserved, in part, by drug-induced alterations in frontal cortical dopamine turnover.THC
Just say know
Stoned as a newt?
The nectar of delight
Rodent cannabis abuse
Cannabis and schizophrenia
Cannabis use and dopamine risk factor for schizophrenia questioned
Altered architecture of mesolimbic dopamine system in cannabis dependence
01 02 03 04 05 06 07 08 09 10 11 12 13 14 15
The Hedonistic Imperative
When Is It Best To Take Crack Cocaine?
The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family